Low BACH2 Expression Predicts Adverse Outcome in Chronic Lymphocytic Leukaemia

SIMPLE SUMMARY: Chronic lymphocytic leukaemia (CLL) is the most frequent type of leukaemia with a highly variable presentation, clinical course, and outcome. The overall aim of our study was to determine the clinical and functional significance of two B-cell regulators, BACH2 and BCL6, in CLL. The r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciardullo, Carmela, Szoltysek, Katarzyna, Zhou, Peixun, Pietrowska, Monika, Marczak, Lukasz, Willmore, Elaine, Enshaei, Amir, Walaszczyk, Anna, Ho, Jia Yee, Rand, Vikki, Marshall, Scott, Hall, Andrew G., Harrison, Christine J., Soundararajan, Meera, Eswaran, Jeyanthy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750551/
https://www.ncbi.nlm.nih.gov/pubmed/35008187
http://dx.doi.org/10.3390/cancers14010023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750551/
https://www.ncbi.nlm.nih.gov/pubmed/35008187
http://dx.doi.org/10.3390/cancers14010023

Ejemplares similares